Old Port Advisors Eli Lilly & CO Transaction History

Old Port Advisors

$360 Billion
Q3 2024

A detailed history of Old Port Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Old Port Advisors holds 1,266 shares of LLY stock, worth $997,848. This represents 0.31% of its overall portfolio holdings.

Number of Shares

1,266

Previous 1,266 -0.0%

Holding current value

$997,848

Previous $1.15 Billion 2.13%

% of portfolio

0.31%

Previous 0.34%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$724.87 - $909.04 $42,042 - $52,724	58 Added 4.8%	1,266 $1.15 Billion
Q1 2024 Jun 26, 2024	SELL	$592.2 - $792.28 $30,202 - $40,406	-51 Reduced 4.05%	1,208 $940 Million
Q4 2023 Jun 26, 2024	BUY	$525.19 - $619.13 $46,741 - $55,102	89 Added 7.61%	1,259 $734 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $99,546 - $137,239	-229 Reduced 16.37%	1,170 $628 Million
Q1 2023 Apr 12, 2023	SELL	$310.63 - $364.82 $8,076 - $9,485	-26 Reduced 1.82%	1,399 $509 Million
Q4 2022 Jan 11, 2023	SELL	$321.55 - $374.67 $30,868 - $35,968	-96 Reduced 6.31%	1,425 $521 Million
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $24,311 - $27,705	82 Added 5.7%	1,521 $504,000
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $5,017 - $5,890	18 Added 1.27%	1,439 $471,000
Q1 2022 Apr 12, 2022	BUY	$234.69 - $291.66 $37,315 - $46,373	159 Added 12.6%	1,421 $416,000
Q4 2021 Jan 12, 2022	BUY	$224.85 - $279.04 $14,390 - $17,858	64 Added 5.34%	1,262 $327,000
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $29,472 - $36,270	133 Added 12.49%	1,198 $273,000
Q2 2021 Jul 20, 2021	BUY	$180.55 - $233.54 $192,285 - $248,720	1,065 New	1,065 $252,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Port Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Old Port Advisors with notifications on news.

Account

Old Port Advisors Eli Lilly & CO Transaction History